Pharma Companies Navigate Their Way through Ac-225 amidst Supply Constraints
Pharma companies have been increasingly investing in developing targeted alpha therapies for cancer treatment, using alpha-emitting isotopes such as Ac-225. However, the current supply for Ac-225 is limited, and thus,...



